Comparison of the effect of Persica mouthwash and normal saline in reducing ventilator-induced respiratory infectio

Phase 3

Conditions: Reduce ventilator infection.
????????? ????? ????? ? ????????

Registration Number: IRCT20101207005335N2

Lead Sponsor: Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 40

Inclusion Criteria

The patient’s age should be between1 month and 14 years old
The patient had to be admitted to the intensive care unit in Less than 12 hours
He/she had not been hospitalized in any other wards before being admitted to the ICU.
He/she did not take antibiotics before admission, had no history of allergies to plant compounds, had no chronic disease and immune system disorder, as well as any specific damage caused by endotracheal intubation or airway.
He/she had no specific lesion in or around the mouth.

Exclusion Criteria

Causes any specific damage by endotracheal intubation or airway or any other physical factor
The patient's legal guardian is unwilling to enter the study.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body temperature. Timepoint: Done in 5 days. Four times a day every 6 hours,. Method of measurement: Mercury Therommeter.;White blood cell count. Timepoint: It was performed four times a day every 6 hours for 5 days. Method of measurement: Based on the patient's blood test result (CBC).;Blood oxygenation. Timepoint: It was performed four times a day every 6 hours for 5 days. Method of measurement: Based on the blood pulse oximetry shown by the monitoring device.;Chest radiography. Timepoint: Before the intervention and after the intervention. Method of measurement: Chest radiography.;Culturing tracheal secretions and scoring them in the Clinical benchmark of Lung infection (cpis). Timepoint: Before the intervention and after the intervention. Method of measurement: Clinical Pulmonary Infection Score.

Secondary Outcome Measures